What is the recommended treatment and monitoring plan for a patient with Marfan syndrome?

Management of Marfan Syndrome

All patients with Marfan syndrome should receive either a beta blocker or an ARB at maximally tolerated doses to slow aortic root dilation, with combination therapy being reasonable for additional benefit 1.

Medical Therapy

First-Line Pharmacologic Treatment

• Start either a beta blocker OR an ARB at diagnosis, titrating to maximally tolerated doses unless contraindicated (Class I, Level A recommendation) 1
  • Beta blockers reduce heart rate and myocardial contractility to slow aortic root growth
  • ARBs have shown equivalent efficacy in randomized trials comparing them to beta blockers
  • Combination therapy with both a beta blocker AND an ARB is reasonable and may provide additional slowing of aortic root growth based on meta-analyses showing superior outcomes over 3-5 years (Class IIa, Level C-LD) 1

The evidence shows no significant difference between beta blockers and ARBs when used as monotherapy for preventing aortic root growth or clinical events (dissection, surgery). However, adding an ARB to beta-blocker therapy has demonstrated incremental benefit in multiple trials 1.

Cardiovascular Surveillance

Initial Imaging at Diagnosis

• Obtain transthoracic echocardiogram (TTE) immediately to measure aortic root and ascending aorta diameters 1
• Repeat TTE at 6 months to establish the rate of aortic growth 1
• After initial TTE, obtain CT or MRI of the entire thoracic aorta to confirm measurements and assess segments not well-visualized on echo (Class IIa recommendation) 1
  • This is particularly important as patient-specific factors like pectus deformities may limit TTE visualization 1

Ongoing Surveillance Protocol

For stable aortic dimensions:

• Annual TTE if aortic root <4.5 cm and growth rate <0.5 cm/year 2
• If TTE inadequate, use CT or MRI 1

For larger or rapidly growing aortas:

• Every 6 months if diameter >4.5 cm OR growth rate >0.5 cm/year 2
• More frequent imaging as surgical thresholds approach 1

After aortic root replacement:

• Annual MRI or CT of entire thoracic aorta initially, then every 2 years if stable after 2 years (Class I recommendation) 1
• Surveillance imaging every 3-5 years for abdominal aortic aneurysm (Class IIa recommendation) 1
  • This is critical because long-term complications include aneurysms in the distal aorta and dissection distal to the graft 1

Surgical Intervention Thresholds

Definitive Indications for Aortic Root Replacement

Operate when aortic root diameter reaches ≥5.0 cm (Class I, Level B-NR recommendation) 1

Earlier Surgery is Reasonable at ≥4.5 cm When High-Risk Features Present:

• Family history of aortic dissection at small diameter (<5.0 cm) or age <50 years
• Rapid aortic growth (>0.5 cm/year, especially >1 cm/year)
• Progressive aortic regurgitation
• Severe mitral regurgitation
• Planned pregnancy or need for other major surgery 2, 3

Surgery at ≥4.5 cm with these features is reasonable when performed by experienced surgeons in a Multidisciplinary Aortic Team (Class IIa, Level B-NR) 1

Alternative Surgical Threshold

Consider surgery when maximal aortic root area (cm²) to patient height (m) ratio ≥10 (Class IIa, Level C-LD) 1

Critical Pitfalls to Avoid

1. Do not delay diagnosis in children: The diagnostic criteria have age-dependent penetrance, so molecular FBN1 testing may be necessary in equivocal pediatric cases 2

2. Do not stop surveillance after root replacement: Patients remain at risk for distal aortic aneurysms and dissection, particularly if they smoke or have had previous root surgery 1

3. Pregnancy requires heightened vigilance: Women with aortic root >4.0 cm at pregnancy onset face substantially increased cardiovascular risk 4

4. Avoid high-intensity static exercise: While low-to-moderate intensity dynamic exercise may be beneficial, high-intensity static exercise should be discouraged 4, 5

5. Maintain lifelong beta blockade post-operatively: All patients should continue medical therapy indefinitely after surgery 3

Multidisciplinary Management Requirements

Marfan syndrome requires coordinated care involving:

• Cardiology (skilled in aortic disease management)
• Cardiovascular surgery (experienced in aortic root procedures)
• Ophthalmology (for ectopia lentis monitoring)
• Genetics (for FBN1 testing and family counseling)
• Orthopedics (for skeletal manifestations)

The diagnosis remains primarily clinical using the modified Ghent criteria, as FBN1 mutations are detected in only 90-95% of unequivocal cases 2. Diagnosis requires aortic root dilation plus either ectopia lentis, pathogenic FBN1 mutation, or multiple systemic features 2.